DK175535B1 - Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid - Google Patents

Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid Download PDF

Info

Publication number
DK175535B1
DK175535B1 DK198801147A DK114788A DK175535B1 DK 175535 B1 DK175535 B1 DK 175535B1 DK 198801147 A DK198801147 A DK 198801147A DK 114788 A DK114788 A DK 114788A DK 175535 B1 DK175535 B1 DK 175535B1
Authority
DK
Denmark
Prior art keywords
plasmid
ser
amino acid
fusion protein
target peptide
Prior art date
Application number
DK198801147A
Other languages
Danish (da)
English (en)
Other versions
DK114788D0 (da
DK114788A (da
Inventor
Koji Magota
Takehiro Oshima
Shoji Tanaka
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Publication of DK114788D0 publication Critical patent/DK114788D0/da
Publication of DK114788A publication Critical patent/DK114788A/da
Application granted granted Critical
Publication of DK175535B1 publication Critical patent/DK175535B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198801147A 1987-03-04 1988-03-03 Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid DK175535B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4779687 1987-03-04
JP4779687 1987-03-04

Publications (3)

Publication Number Publication Date
DK114788D0 DK114788D0 (da) 1988-03-03
DK114788A DK114788A (da) 1988-09-05
DK175535B1 true DK175535B1 (da) 2004-11-29

Family

ID=12785332

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198801147A DK175535B1 (da) 1987-03-04 1988-03-03 Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid

Country Status (11)

Country Link
US (1) US4987070A (fr)
EP (1) EP0281418B1 (fr)
JP (1) JPH0687788B2 (fr)
AT (1) ATE117023T1 (fr)
AU (1) AU607973B2 (fr)
CA (1) CA1340830C (fr)
DE (1) DE3852706T2 (fr)
DK (1) DK175535B1 (fr)
ES (1) ES2065907T3 (fr)
GR (1) GR3015328T3 (fr)
HU (1) HU210625B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0440311A1 (fr) * 1985-06-20 1991-08-07 Fujisawa Pharmaceutical Co., Ltd. Procédé de production d'un polypeptide humain alpha atrionatriuretique
DE3805150A1 (de) * 1987-04-11 1988-10-20 Hoechst Ag Gentechnologisches verfahren zur herstellung von polypeptiden
DE3716722A1 (de) * 1987-05-19 1988-12-01 Hoechst Ag Gentechnologisches verfahren zur herstellung von angiogeninen
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
JP2535398B2 (ja) * 1989-01-17 1996-09-18 サントリー株式会社 アミド化ペプチドの製造方法
JP2857684B2 (ja) * 1989-05-04 1999-02-17 ジェネンテク，インコーポレイテッド ヒトリラキシンの単離のための方法および組成物
US5202239A (en) * 1990-08-07 1993-04-13 Scios Nova Inc. Expression of recombinant polypeptides with improved purification
US6077694A (en) * 1990-09-21 2000-06-20 The United States Of America As Represented By The Department Of Health And Human Services Method for over-expression and rapid purification of biosynthetic proteins
US5525491A (en) * 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
JP3531947B2 (ja) * 1991-08-19 2004-05-31 第一サントリーファーマ株式会社 ペプチドの製造方法
ATE253639T1 (de) * 1991-08-19 2003-11-15 Daiichi Suntory Pharma Co Ltd Verfahren zur herstellung von peptiden
US5795776A (en) * 1994-03-22 1998-08-18 Bio-Technology General Corp. Expression plasmids regulated by an OSMB promoter
WO1997023639A1 (fr) * 1995-12-22 1997-07-03 Toray Industries, Inc. Procede de production de proteines fusionnees biologiquement actives
ATE529515T1 (de) * 1998-07-10 2011-11-15 Scios Inc Verfahren zur herstellung eines peptids mit einem pi grösser als 8 oder kleiner als 5
MXPA01003770A (es) * 1998-10-13 2002-05-06 Univ Georgia Res Found Peptidos bioactivos estabilizados, y metodos de identificacion, sintesis y uso de los mismos.
US20030190740A1 (en) * 1998-10-13 2003-10-09 The University Of Georgia Research Foundation, Inc Stabilized bioactive peptides and methods of identification, synthesis, and use
US20020090646A1 (en) * 2000-05-03 2002-07-11 Amgen Inc. Calcitonin-related molecules
JP4143300B2 (ja) 2000-05-10 2008-09-03 アスビオファーマ株式会社 遺伝子組換えポリペプチドの生産における副生成物の生成を抑制する方法
WO2003010204A1 (fr) * 2001-07-26 2003-02-06 Advanced Protein Technologies Corp. Procede de preparation de polypeptides d'interet a partir de polypeptides de fusion
AU2003244053A1 (en) 2003-06-03 2005-01-21 Shanghai Centre Of Research And Development Of New Drugs A fusion protein suitable to be expressed high effectively and the production method thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK493878A (da) * 1977-11-08 1979-05-09 Genentech Inc Fremgangsmaade og middel til mikrobiel polypeptid-udrykning
AT373281B (de) * 1977-11-08 1984-01-10 Genentech Inc Verfahren zur herstellung eines strukturgens
BR7807290A (pt) * 1977-11-08 1979-06-12 Genentech Inc Plasmideo,processo para producao de um polipeptido especifico veiculo clonal,cultura bacteriana transformante,processo para produzir uma substancia imunogenica processo para preparar um gene estrutural,e polidesoxirribonucleotido de faixa dupla
US4431739A (en) * 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
CA1200773A (fr) * 1980-02-29 1986-02-18 William J. Rutter Liens d'expression
US4769326A (en) * 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
JPS5869897A (ja) * 1981-10-20 1983-04-26 Gakuzo Tamura Ｄｎａ遺伝子
IE56026B1 (en) * 1982-10-19 1991-03-27 Cetus Corp Cysteine-depleted muteins of biologically active proteins
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
US4711844A (en) * 1983-03-09 1987-12-08 Cetus Corporation Modified signal peptides
GB8308483D0 (en) * 1983-03-28 1983-05-05 Health Lab Service Board Secretion of gene products
GB2140810B (en) * 1983-05-24 1987-07-08 Celltech Ltd Polypeptide and protein products, and process for their production
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US4549986A (en) * 1983-12-23 1985-10-29 The Salk Institute For Biological Studies Human CGRP
US4736023A (en) * 1983-12-23 1988-04-05 The Salk Institute For Biological Studies DNA encoding human CGRP
JPH0672155B2 (ja) * 1984-08-24 1994-09-14 塩野義製薬株式会社 α−ｈＡＮＰ抗血清作製用ポリペプチド
GB8515686D0 (en) 1985-06-20 1985-07-24 Fujisawa Pharmaceutical Co Production of-human atrial natriuretic polypeptide
GB8600754D0 (en) 1986-01-14 1986-02-19 Fujisawa Pharmaceutical Co Human atrial natriuretic polypeptide
EP0440311A1 (fr) * 1985-06-20 1991-08-07 Fujisawa Pharmaceutical Co., Ltd. Procédé de production d'un polypeptide humain alpha atrionatriuretique
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
DE3805150A1 (de) * 1987-04-11 1988-10-20 Hoechst Ag Gentechnologisches verfahren zur herstellung von polypeptiden

Also Published As

Publication number Publication date
ES2065907T3 (es) 1995-03-01
DK114788D0 (da) 1988-03-03
AU1272488A (en) 1988-09-15
DE3852706T2 (de) 1995-05-24
JPS6410999A (en) 1989-01-13
EP0281418A2 (fr) 1988-09-07
JPH0687788B2 (ja) 1994-11-09
EP0281418B1 (fr) 1995-01-11
HU210625B (en) 1995-06-28
HUT46071A (en) 1988-09-28
CA1340830C (fr) 1999-11-30
EP0281418A3 (en) 1989-04-26
DE3852706D1 (de) 1995-02-23
US4987070A (en) 1991-01-22
ATE117023T1 (de) 1995-01-15
AU607973B2 (en) 1991-03-21
DK114788A (da) 1988-09-05
GR3015328T3 (en) 1995-06-30

Similar Documents

Publication Publication Date Title
DK175535B1 (da) Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid
JP2545686B2 (ja) ポリペプチドの製造方法
EP0195691B1 (fr) Procédé pour la préparation de précurseurs d'insuline et procédé de préparation d'insuline humaine
DK173910B1 (da) Ikke-glycosylerede polypeptider, som har en intakt lysin-isoleucin-binding i den position, der svarer til aminosyrerne 158-159 i det native prourokinasemolekyle, og som har tilstrækkeligt af den i fig. 4A og 4B viste aminosyresekvens til, ...
JP3701201B2 (ja) 大腸菌エンテロトキシンｉｉシグナルペプチド変形体およびその変形体と異種タンパク質の融合タンパク質を発現する微生物
NO308667B1 (no) FremgangsmÕte for fremstilling av fusjonsproteiner
NO327325B1 (no) Ekspresjonsvektor, vertcelle samt fremgangsmate for fremstilling av et peptidprodukt.
AU698872B2 (en) Generation of human insulin
NO175266B (no) Fremgangsmåte for fremstilling av et humant t-PA protein som mangler en eller flere av de N-bundne karbohydratrestene, DNA, hybridvektor samt transformert eukaryot vertscelle som er i stand til å uttrykke et humant t-PA protein
NO308543B1 (no) FremgangsmÕte for fremstilling av hirudinderivater, samt rekombinant DNA og rekombinant vektor
CA2051375C (fr) Procede et compositions pour l'isolement de la relaxine humaine
JPH11503002A (ja) 酵素的に活性な組換えカルボキシペプチダーゼｂの製造
CA2094512A1 (fr) Polypeptides de fusion
FI105482B (fi) Menetelmä heterologisen proteiinin valmistamiseksi eukaryoottisessa isäntäsolussa
AU665034B2 (en) Production of human parathyroid hormone from microorganisms
US7892787B2 (en) Method for production of recombinant growth hormone in form of hybrid protein
JPH01104168A (ja) Ｃ−末端α−アミド化酵素
EP0321940A2 (fr) Méthode pour la préparation d'hormone de croissance humaine sous forme pure
US4874743A (en) DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor-like polypeptides
Ohsuye et al. Expression of chemically synthesized α-neo-endorphin gene fused to E. coli alkaline phosphatase
NO179046B (no) Fremgangsmåte for fremstilling av biologisk aktivt human enkelt kjede urokinase-type plasminogenaktivator
JPH09296000A (ja) プロセッシング酵素を用いたキメラタンパク質の切断方法
JPH0710900A (ja) 成長ホルモン放出因子を含むハイブリドポリペプチド
JP2845468B2 (ja) ヒト甲状腺由来Ｃ―末端α―アミド化酵素
EP0384750B1 (fr) Procédé pour la production de 5-lipoxygénase humaine

Legal Events

Date Code Title Description
PUP Patent expired